(Vinkhuyzen et al. 2012) |
EPQ |
Extraversion |
GCTA |
~ 12,000 EUR |
N |
6% (3%) |
Neuroticism |
|
|
12% (3%) |
(Verweij et al. 2012) |
TPQ |
HA |
GCTA |
~ 8,000 EUR |
NA |
6.6% (3.7%) |
NS |
9.9% (3.6%) |
RD |
4.2% (3.6%) |
Persistence |
8.1% (3.7%) |
(Power and Pluess 2015) |
NEO-PI-R |
Neuroticism |
GCTA |
5,011 EUR |
NA |
15% (8%) |
|
|
Openness |
|
|
|
21% (8%) |
(de Moor et al., 2015) |
IRT |
Neuroticism |
GCTA |
63,661 EUR (NTR, QIMR cohorts) |
1 SNP |
14.7% (5.5%) |
15.7% (8.3%) |
(van den Berg et al. 2016) |
IRT |
Extraversion |
GCTA |
3,597 and 3,369 (NTR, QIMR cohorts) |
N |
4.9% (0.8%) |
(Okbay et al. 2016) |
EPQ, NEO |
Neuroticism |
LDSC |
170,911 EUR |
11 SNPs |
9.1% (0.7%) |
(Smith et al. 2016) |
EPQ (short) |
Neuroticism |
GCTA |
~ 106,000 EUR (UK Biobank) |
9 SNPs |
15% (0.7%) |
(Lo et al. 2016) |
EPQ, NEO-FFI |
Extraversion |
LDSC |
59,176 EUR (23andMe) |
5 SNPs |
18.1% (1.0%) |
Neuroticism |
2 SNPs |
11.9% (1.6%) |
Conscientiousness |
1 SNP |
9.6% (0.9%) |
Agreeableness |
|
8.5% (0.9%) |
Openness |
10.7% (0.9%) |
(Docherty et al. 2016) |
EPQ |
Neuroticism |
GCTA |
9,633 EAS (MDD and control women) |
NA |
10% (3%) |
(Luciano et al. 2017) |
EPQ (short) |
Neuroticism |
LDSC |
329,821 EUR (UK Biobank) |
116 SNPs |
10.8% (0.5%) |
(Nagel et al. 2017) |
EPQ (short), NEO, NEO-FFI |
Neuroticism |
LDSC |
449,484 EUR (UK Biobank, 23andMe, GPC1) |
136 SNPs |
10.0% (0.3%) |